Category: Wall Street Beat
Shares of InVivo Therapeutics are slated to begin trading today on the NASDAQ stock exchange.
ViewRay rescinds its planned $52 million initial public offering, saying it might float a private offering instead.
ViewRay yesterday became the latest medical device company to scrap an initial public offering, withdrawing a flotation that would have raised $52 million for its MRI-guided radiation therapy technology.
Here's a look at some of the top Wall Street stories for medical device companies this week: Report: ViewRay tables $52m IPO; GI Dynamics exercises 1-for-10 reverse split; BSD Medical rebrands as Perseon, wins expanded FDA nod for MicroThermX; Positron conducts 1-for-400 reverse stock split
GI Dynamics has conducted a 1-for-10 reverse stock split in an effort to boost its lagging stock price.
GI Dynamics (ASX:GID) said it conducted a 1-for-10 reverse stock split in an effort to boost its flagging share price.
Cardiac imaging specialist Positron conducts 1-for-400 reverse stock split.
Cardiac imaging specialist Positron Corp. (OTC:POSC) said it conducted a 1-for-400 reverse stock split yesterday.
ViewRay reportedly postpones its planned initial public offering, which would have raised $52 million at the midpoint.
ViewRay postponed its initial public offering with which it planned to raise $52 million for its MRI-guided radiation therapy technology, Renaissance Capital reported.
Oakwood Village, Ohio-based ViewRay had planned to float 4 million shares at $12 to $14 apiece.
BSD Medical, which rebranded as Perseon earlier this year, wins an expansion of its 510(k) clearance from the FDA for its MicroThermX ablation device for laparoscopies using image guidance.